INTERNATIONAL PATENT: SILENCE THERAPEUTICS GMBH FILES APPLICATION FOR "CONJUGATED NUCLEIC ACIDS AND NUCLEIC ACIDS COMPRISING LOCKED NUCLEOSIDES AND INVERTED NUCLEOTIDES FOR INHIBITING GENE EXPRESSION IN A CELL"

GENEVA, Aug. 11 -- SILENCE THERAPEUTICS GMBH (Robert-Rossle-Strasse 1013125 Berlin) filed a patent application (PCT/EP2025/052612) for "CONJUGATED NUCLEIC ACIDS AND NUCLEIC ACIDS COMPRISING LOCKED NUCLEOSIDES AND INVERTED NUCLEOTIDES FOR INHIBITING GENE EXPRESSION IN A CELL" on Jan 31, 2025. With publication no. WO/2025/163186, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SCHOLLKOPF, Sophie (Robert-Rossle-Strasse 1013125 Berlin), WAS, Nina (Robert-Rossle-Strasse 1013125 Berlin), BETHGE, Lucas (Robert-Rossle-Strasse 101...